TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Fuso Pharmaceutical Industries,Ltd. ( (JP:4538) ) has issued an update.
Fuso Pharmaceutical Industries, Ltd. has announced its medium-term management plan, FUSO VISION 2030 Next Stage, aimed at addressing industry challenges and ensuring sustainable growth. The plan includes significant investments in production facilities, research and development, and digital transformation to enhance corporate value and meet unmet medical needs. The company aims to achieve sales of over 70 billion yen and an ROE of over 8.0% by 2030, despite expected profit declines until 2028 due to initial investments.
More about Fuso Pharmaceutical Industries,Ltd.
Fuso Pharmaceutical Industries, Ltd. operates in the pharmaceutical industry, focusing on the production of basic pharmaceutical products. The company prioritizes the stable supply of medicines essential for healthcare, with a market focus on dialysis supplies, kidney and urinary system products, and infertility treatment solutions.
Average Trading Volume: 17,054
Technical Sentiment Signal: Strong Buy
Current Market Cap: Yen19.61B
See more data about 4538 stock on TipRanks’ Stock Analysis page.